Home » Topics » BioWorld Science

BioWorld Science
RSS

S100-B found to be a peripheral biomarker for estimating addiction treatment efficacy

Sep. 12, 2019

ANKRD12 as a novel biomarker in schizophrenia and bipolar disorder

Sep. 12, 2019

Positive CTC data from phase II TYME-88-PANC study of SM-88

Sep. 12, 2019

Tiziana presents phase I results for nasal foralumab

Sep. 12, 2019

Molecular Partners initiates first-in-human study of MP-0310

Sep. 12, 2019

Murine model reveals TRPA1 loss is involved in age-related dilated cardiomyopathy

Sep. 12, 2019

Pfizer reports preliminary data from phase II pediatric study of 20vPnC candidate

Sep. 10, 2019

Translate Bio discontinues MRT-5201 for OTC deficiency, prioritizes pulmonary disease programs

Sep. 10, 2019

Alector begins phase II study of AL-001 for frontotemporal dementia

Sep. 10, 2019

Prometic initiates phase I study of PBI-4547

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...